Ming Chen

Mr. Ming Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
XCXiaohe Chen
Xiaohe Chen
AFAimei Feng
Aimei Feng
HGHaifei Guo
Haifei Guo
JZJue Zeng
Jue Zeng
MCMing Chen
Ming Chen
Acute myeloid leukemia (AML) exhibits pronounced heterogeneity, necessitating deep molecular characterization for precision therapy. Lactate metabolism and histone lactylation, influencing tumor biology via epigenetic regulation and immune microenvironment remodeling, represent an emerging focus. This study combines single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (bulk RNA-seq) data to investigate the prognostic value of lactate/lactylation-associated genes (LL-genes, defined as genes involved in lactate metabolism and histone lactylation regulation) in AML. Specifically, Seurat was utilized for scRNA-seq clustering with cell annotation/validation via the TISCH2 database. Gene Set Variation Analysis (GSVA) assessed lactate/lactylation pathway activity. In bulk RNA-seq, ConsensusClusterPlus enabled molecular subtyping, while ten machine learning algorithms constructed a prognostic model. scRNA-seq revealed specific LL-gene overexpression in malignant progenitors, concomitant with elevated lactate metabolism-lactylation activity (LML-CAS; Lactate Metabolism-Lactylation Modification Combined Activity Score), enhanced metabolic-inflammatory synergy, and immunosuppression (increased Tregs/M2 macrophages). Molecular subtyping identified two clusters (A/B) exhibiting divergent survival outcomes (Cluster A: poorer prognosis). An optimized 7-gene prognostic model demonstrated high accuracy, predicting reduced chemotherapy response among high-risk patients. Transcriptomic profiling indicated lactylation-associated immunosuppression (e.g., downregulated CXCL9/10-CXCR3 axis, enrichment of T cell exhaustion markers) and heightened in silico-predicted sensitivity to BCL-2/FGFR inhibitors (ABT-737/AZD4547) in high-risk patients. qRT-PCR confirmed RNA-level dysregulation of key LL-genes (IFI16, THOC2, HIST1H2BD, ARPP19), aligning with bioinformatic predictions. Western blot analysis further validated aberrant protein expression of IFI16 and THOC2 in AML specimens, reinforcing their dysregulation. Collectively, integrated analyses uncovered lactate/lactylation-associated heterogeneity in AML. Our machine learning-based prognostic model predicts survival, therapeutic response, and drug sensitivity, suggesting a potential strategy for precision therapeutics in AML.

28 November 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XCXiaohe Chen
Xiaohe Chen
AFAimei Feng
Aimei Feng
FCFan Chen
Fan Chen
JZJue Zeng
Jue Zeng
MCMing Chen
Ming Chen
Background: Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy with significant clinical challenges due to its heterogeneity and high relapse rate. Dysregulated ribosome biogenesis is a recognized driver of tumorigenesis and therapy resistance, but its comprehensive impact on AML prognosis and the immune microenvironment remains to be fully elucidated. Methods: We constructed an AML single-cell atlas and quantified ribosome biogenesis activity. A prognostic ribosome biogenesis signature (RBS) was developed through integrated machine learning and interpreted using the SHapley Additive exPlanations (SHAP) framework. We evaluated the RBS associations with prognosis, tumor immune microenvironment, immunotherapy response, and drug sensitivity. Key findings were validated by qPCR, Western blot, and molecular docking. Results: Single-cell analysis revealed significantly elevated ribosome biogenesis activity scores (RAS, a composite metric quantifying cellular ribosome synthesis capacity) in AML stem and progenitor cells. The RBS model, established using a Random Survival Forest algorithm, demonstrated robust prognostic power. SHAP interpretation identified EXOSC2 as the top predictor. Low-RBS patients displayed an immune-activated microenvironment and heightened immunotherapy response. Molecular docking indicated high-affinity binding of ouabain and digoxin to EXOSC2. Conclusion: Our study delineates the critical role of ribosome biogenesis in AML progression and establishes an interpretable RBS prognostic signature. This tool effectively assesses immunotherapy responsiveness and reveals novel targeting opportunities, providing valuable insights for clinical decision-making to improve AML outcomes.

1 January 2022
Verified
Journal Article
Closed access
XCXiaohe Chen
Xiaohe Chen
LZLifen Zhao
Lifen Zhao
TYTian Yu
Tian Yu
JZJue Zeng
Jue Zeng
MCMing Chen
Ming Chen

28 November 2024 in Heliyon
Verified
Journal Article
Open access
YLYing Lin
Ying Lin
MCMing Chen
Ming Chen
XZXuelian Zhu
Xuelian Zhu
XCXiaoya Cui
Xiaoya Cui
SSSuyu Sun
Suyu Sun
XHXingzhong Hu
Xingzhong Hu
The relationship between tumour necrosis factor (TNF) levels and disease progression is well-established. However, the impact of changes in the level of TNF hydrolase (A-disintegrin and metalloenzyme 17; ADAM17) in HIV patients remains to be fully elucidated. Between March 1 and December 31, 2017, data were collected from 64 HIV-positive individuals in Wenzhou. Based on their history of antiviral treatment at the time of enrollment, these patients were categorized into two cohorts: an antiviral-treated group and an untreated HIV group. Then, the serum ADAM17 levels of each group were measured and analysed. In comparison to the antiviral-treated group and the control group, the untreated HIV group exhibited a significantly elevated serum ADAM17 level (p < 0.001). A significant negative correlation was observed between serum ADAM17 levels and CD4+ T cell counts in the untreated HIV group (r = −0.486, p = 0.001). ROC curve analysis revealed that the pre-treatment serum ADAM17 level in the untreated HIV group had moderate diagnostic accuracy for the AIDS stage (area under the curve: 0.703, p = 0.028). Additionally, serum ADAM17 levels were positively correlated with ADAM17 expression on the surface of leukocytes (r = 0.367, p = 0.018). Serum ADAM17 levels are significantly elevated in HIV patients and are correlated with disease progression and immune reconstitution.

8 September 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AFAimei Feng
Aimei Feng
XCXiaohe Chen
Xiaohe Chen
FCFan Chen
Fan Chen
XWXiaowu Wang
Xiaowu Wang
MPMengjia Peng
Mengjia Peng
MCMing Chen
Ming Chen
Background: Polyamine metabolism is an important metabolic dependency in cancer, but its cellular organization and clinical relevance in acute myeloid leukemia (AML) remain unclear. Methods: We integrated publicly available single-cell RNA sequencing (scRNA-seq) data from 41 AML samples (198,846 cells) and bulk transcriptomic profiles from 712 AML patients across independent cohorts. Polyamine activity was quantified using a 76-gene signature. Consensus clustering and machine-learning algorithms were used for molecular classification and prognostic modeling. Immune features and gene dependency were further evaluated. CCT6A was further validated by quantitative real-time PCR (qPCR), small interfering RNA (siRNA) silencing, cell viability and apoptosis assays, Western blotting, intracellular polyamine and ODC1 activity measurements, and spermidine rescue. Results: Polyamine activity was preferentially enriched in AML blasts and associated with increased stemness, proliferation, and DNA damage response, together with impaired differentiation. Two molecular subtypes with distinct metabolic and immune features were identified. The Random Survival Forest model effectively stratified patients into prognostic risk groups, achieving external-validation area under the curve (AUC) values up to 0.774. High-risk patients exhibited distinct immune and stromal microenvironmental features. CCT6A was overexpressed in AML samples, and its silencing suppressed cell viability, promoted apoptosis, and reduced ODC1 activity and intracellular polyamine levels. Importantly, exogenous spermidine substantially restored cell viability following CCT6A knockdown. Conclusion: Polyamine-active AML blast states have prognostic and immune relevance, while CCT6A is functionally linked to AML cell fitness and polyamine homeostasis.